Drug Therapy [topp]
Hypertriglyceridaemia [fndg]
Fibrates [orch, phsu]
Omega-3 Fatty Acids [bacs, lipd, phsu]
reduction [npop]
Low Density Lipoprotein Cholesterol [bacs, strd]
Patients [podg]
At risk [qlco]
acute [tmco]
cardiovascular events [fndg]
Lipid [lipd]
Management [ocac]
Primary [qlco]
Secondary Prevention [topp]
setting [ftcn]
Serum triglyceride levels [lbpr]
mg dl [qnco]
Abnormal [qlco]
Increased [qnco]
coronary artery disease [dsyn]
Men [popg]
Women [popg]
serum triglycerides [lbpr]
Derived [qlco]
Dietary [food]
Endogenous [ftcn]
Biosynthetic Pathways [moft]
Triglyceride Metabolism [moft]
Complex [qlco]
regulatory [rnlw]
IMPACT [gngm]
production [ocac]
Disposal [acty]
Multiple [qnco]
Lipoprotein [aapp, bacs]
Species [idcn]
Hypertriglyceridaemia [fndg]
Highly [qlco]
Multiple [qnco]
forms [qlco]
Dyslipidaemia [dsyn]
Therapeutic Intervention [topp]
Fibric Acid Derivatives [orch]
omega-3 [bacs, lipd, phsu]
Fish Oils [bacs, lipd, phsu]
reductions [npop]
Fasting [fndg]
Postprandial [tmco]
serum triglyceride [lbpr]
Concentrations [menp]
Variety [cnce]
prospective [resa]
placebo [topp]
Controlled Clinical Trial [inpr]
Agent [chvf]
IMPACT [gngm]
Multiple [qnco]
CARDIOVASCULAR [bdsy]
End Point [qlco]
